株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

慢性腎疾患 (CKD) :世界市場・技術 (2023年)

Chronic Kidney Disease: Global Markets and Technologies Through 2023

発行 BCC Research 商品コード 830795
出版日 ページ情報 英文 153 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
慢性腎疾患 (CKD) :世界市場・技術 (2023年) Chronic Kidney Disease: Global Markets and Technologies Through 2023
出版日: 2019年04月22日 ページ情報: 英文 153 Pages
概要

世界の慢性腎疾患 (CKD) 市場は、2018年の790億米ドルから2023年までに950億米ドルへ達すると予測され、この間は3.8%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界の慢性腎疾患 (CKD) 市場について調査分析し、市場の概要、市場の動向分析と予測、市場の促進要因・抑制要因のほか、規制環境、特許情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 慢性腎疾患の背景

  • 腎臓の機能
  • 慢性腎疾患 (CKD) の治療・管理
  • 医療機器による介入
  • 腎臓透析
  • 腎臓透析の原理
  • 腎臓透析の機能
  • 腎臓透析の種類
  • 腎臓移植
  • 慢性腎疾患 (CKD) 管理向けソフトウェア・モバイルアプリケーション

第4章 市場概要

  • 概要
  • 腎臓透析市場の影響要因
  • 規制・医療費償還情勢

第5章 市場セグメント分析

  • セグメント分析:治療介入別

第6章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第7章 特許レビュー/新規開発

  • 特許:年度別
  • 特許:種類別
  • 特許:企業別
  • 特許:国別
  • 特許:譲受人別
  • 新たな開発

第8章 競合状況

  • 概要
  • 主なM&A

第9章 企業プロファイル

BCC Researchについて

図表

List of Tables

  • Summary Table: Global Market for Chronic Kidney Disease, by Type, Through 2023
    • Table 1: Stages of Chronic Kidney Disease: A Clinical Action Plan
    • Table 2: Awareness, Treatment and Measures of Control of Risk Factors, 1998-2012
    • Table 3: Incidence of ESRD, by Country, 2015
    • Table 4: Prevalence of ESRD, by Country, 2015
    • Table 5: Incidence of ESRD Patients (Due to Diabetes), by Country, 2015
    • Table 6: Kidney Transplant Rates, by Country, 2015
    • Table 7: Pathologies and Etiologies Associated with CKD
    • Table 8: Common Medications Associated with Chronic Kidney Disease
    • Table 9: Prevalence of Hypertension and Dyslipidemia, by CKD Stage
    • Table 10: Patients Share of Commonly Prescribed Medication for Chronic Kidney Disease
    • Table 11: Recommended Antihypertensive Agents for Patients with Chronic Kidney Disease and Hypertension
    • Table 12: Commonly Prescribed Ace Inhibitors
    • Table 13: Commonly Prescribed Angiotensin Receptor Blockers
    • Table 14: Commonly Prescribed Beta Blockers
    • Table 15: Commonly Prescribed Calcium Channel Blockers
    • Table 16: Commonly Prescribed Phosphate Binders
    • Table 17: Commonly Prescribed Statins
    • Table 18: Commonly Prescribed Bile Acid Sequestrants
    • Table 19: Commonly Prescribed Fibrates
    • Table 20: Commonly Prescribed Diuretics
    • Table 21: Commonly Prescribed Erythropoiesis-Stimulating Agents
    • Table 22: Commonly Prescribed Iron Supplements
    • Table 23: Commonly Prescribed Glucose Management Drugs
    • Table 24: Commonly Prescribed Medication for Chronic Kidney Disease
    • Table 25: Commonly Prescribed Immunosuppressant Drugs
    • Table 26: Immunosuppression Maintenance Regimens
    • Table 27: Immunosuppression Induction Drug Therapies
    • Table 28: Global Market for Chronic Kidney Disease, by Type, Through 2023
    • Table 29: Reimbursement of Dialysis Services per Week, 2011-2013
    • Table 30: Global Market for CKD Pharmaceutical Drugs, by Type, Through 2023
    • Table 31: Global Market for CKD Stage 1-5 Drugs, by Region, Through 2023
    • Table 32: Common Drug Classes Used, by Part D-Enrolled Dialysis Patients, 2013
    • Table 33: Global Market for Dialysis Drugs, by Region, Through 2023
    • Table 34: Global Market for Post-Transplantation Drugs, by Region, Through 2023
    • Table 35: Global Market for Dialysis Devices, by Type, Through 2023
    • Table 36: Global Market for Hemodialysis, by Region, Through 2023
    • Table 37: Key Peritoneal Products and Manufacturers
    • Table 38: Global Market for Peritoneal Dialysis, by Region, Through 2023
    • Table 39: Global Market for Dialysis Devices, by Product, Through 2023
    • Table 40: Global Market for Dialysis Accessories, by Region, Through 2023
    • Table 41: Global Market for Dialysis Equipment, by Region, Through 2023
    • Table 42: Global Market for Dialysate and Other Solutions, by Region, Through 2023
    • Table 43: Global Market for Dialysis Devices, by End User, Through 2023
    • Table 44: Global Market for Medical Care Centers, by Region, Through 2023
    • Table 45: Global Market for In-Home Dialysis, by Region, Through 2023
    • Table 46: Global Market for Chronic Kidney Disease, by Region, Through 2023
    • Table 47: North American Market for Chronic Kidney Disease, by Country, Through 2023
    • Table 48: European Market for Chronic Kidney Disease, by Country, Through 2023
    • Table 49: Asia-Pacific Market for Chronic Kidney Disease, by Country, Through 2023
    • Table 50: Rest of the World Market for Chronic Kidney Disease, by Country, Through 2023
    • Table 51: Patents on Renal Dialysis Equipment and Technology, by Year, 2014-2017
    • Table 52: Patents on Renal Dialysis Equipment and Technology, by Type, 2014-2017
    • Table 53: Patents on Renal Dialysis Equipment and Technology, by Company, 2014-2017
    • Table 54: Patents on Renal Dialysis Equipment and Technology, by Country, 2014-2017
    • Table 55: Patent Shares of Renal Dialysis Equipment and Technology, 2014-2017
    • Table 56: Patents on Renal Dialysis Equipment and Technology, by Assignee, 2014-2017
    • Table 57: New Developments in Renal Dialysis, 2014-2017
    • Table 58: Key Mergers and Acquisitions in Renal Dialysis, 2014-2017

List of Figures

  • Summary Figure: Global Market for Chronic Kidney Disease, by Type, 2017-2023
    • Figure 1: Patents on Renal Dialysis Equipment and Technology, by Year, 2014-2017
    • Figure 2: Patents on Renal Dialysis Equipment and Technology, by Type, 2014-2017
    • Figure 3: Patents on Renal Dialysis Equipment and Technology, by Assignee, 2014-2017
    • Figure 4: Global Market Share of Dialysis Medical Devices, by Company, 2017
目次
Product Code: HLC214A

Highlights:

The global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate (CAGR) of 3.8% for the period of 2018-2023.

Pharmaceuticals as a segment of chronic kidney disease market should grow from $68.0 billion in 2018 to reach $81.3 billion by 2023 at a CAGR of 3.6% for the period of 2018-2023.

Medical devices as a segment of chronic kidney disease market should grow from $11.0 billion in 2018 to reach $13.7 billion by 2023 at a CAGR of 4.4% for the period of 2018-2023.

Report Scope:

Five-year projections for market activity and value are provided. Treatment types and trends for acute and chronic kidney failure, pricing considerations for medications, dialysis products (dialysis machines, dialysates and dialyzers), therapies, surgical procedures, companies, industry structure and participating companies are included in the study.

Qualitative information on disease overview, epidemiology and clinical burden of CKD is covered in detail. Further, detailed description about diagnostic methods such as blood tests, medical imaging; treatment, disease management strategies like pharmacological interventions, medical device interventions such as dialysis and kidney transplantation procedures and dietary supplements are covered. Further supporting technologies such as smartphone apps, tools and emerging technologies in dialysis and kidney transplantation procedures are also covered. Special emphasis is given to new, emerging technologies for the treatment of CKD. Market specific information on global dynamics (drivers, challenges and emerging opportunities) are covered. CKD disease management involves tedious labor, safety and cost analyses, knowledge of current policies, regulations and reimbursement. Further clinical trial and patent landscape is also covered in the report. Profiles and the overall competitive landscape of companies/manufacturers engaged in offering drugs and medical equipment for treating CKD is covered in the report.

Quantitative market size and forecast information is covered broadly by treatment, user settings and region. By treatment, the market is categorized into drugs (treatment of complications associated due to CKD, drugs for dialyzed patient groups, post-kidney transplantation procedures are covered) and medical equipment (dialysis-hemodialysis, peritoneal dialysis, kidney transplantation procedure surgical equipment). By user settings the CKD market is categorized into hospitals, specialty clinics and homecare. By region the market is categorized into North America, Europe, Asia-Pacific and RoW (Latin America, Middle East and Africa).

Report Includes:

  • 37 data tables and 22 additional tables
  • A detailed overview of the global markets for Chronic Kidney Disease (CKD)
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on current state of chronic kidney disease, with an emphasis on biomarkers, diagnostic methods, and mobile apps that support effective disease state management
  • Key insight into research on CKD comorbidities such as Diabetes and Metabolic Disease, as well as treatment methods and diagnostics
  • A look at the impact of regulatory, environmental, and legislative issues on the global CKD market
  • Profiles of major market players within the industry, including Abbott Laboratories, Eli Lilly and Co., Eisai, Inc., Merck & Co. and Sanofi-Aventis

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Key Findings

Chapter 3: Background of Chronic Kidney Disease

  • Kidney Function
    • Renal Disease
    • Symptoms
    • Hospitalization for Kidney Disease
    • Costs of Chronic Kidney Disease
    • Epidemiology of Renal Disease
    • Cause of Chronic Kidney Disease
    • Pathology of Chronic Kidney Disease
    • Anemia
    • Diabetic Nephropathy
    • Electrolyte Abnormality
    • Diagnostic Methods for Identification and Detection of Chronic Kidney Disease
    • Clinical Markers for the Detection of Chronic Kidney Disease
  • Treatment and Management of Chronic Kidney Disease (CKD)
    • Pharmaceutical Therapies
    • Antihyperkalemia
    • Antihyperphosphatemia
    • Cholesterol Management Medications
    • Diuretics
    • Erythropoiesis-Stimulating Agents
    • Iron Therapy
    • Glucose Management
    • Other
  • Medical Device Interventions
    • Dialysis
    • Kidney Transplant
  • Renal Dialysis
  • Principles of Renal Dialysis
  • Function of Renal Dialysis
  • Types of Renal Dialysis
    • Hemodialysis
    • Peritoneal Dialysis
    • Additional Medications for Dialysis Patients
    • Medications for CKD Patients on Peritoneal Dialysis
    • Novel Kidney Treatment in Development
    • Portable, Cartridge-Based Hemodialysis Device
    • Wearable Peritoneal Dialysis Device
  • Kidney Transplantation
    • The Transplant Procedure
    • Waiting List for Kidney Transplantation
    • Economics of Kidney Transplant
    • Drugs Used in Conjunction with Kidney Transplantation
    • Immunosuppressant Agents for Kidney Transplant
  • Software and Mobile Applications for Chronic Kidney Disease Management
    • Smartphone Technology and Mobile Apps
    • Mobile Apps for CKD Patients
    • Mobile Apps for CKD Professionals
    • Diet and Nutrition Apps
    • Medication Apps
    • Renal LabApps

Chapter 4: Market Overview

  • Overview
  • Factors Affecting Renal Dialysis Market
    • Drivers of the Renal Dialysis Market
    • Current Challenges for the Renal Dialysis Market
  • Regulations and Reimbursement Landscape
    • U.S. FDA 510(k) Approval
    • Reimbursement Landscape

Chapter 5: Market Segment Analysis

  • Segment Analysis, by Treatment Intervention
    • Pharmaceutical Drugs
    • Medical Device Interventions-Dialysis
    • Analysis of Medical Device Intervention, by Product
    • Analysis of Medical Device Intervention/Dialysis Market, by End User

Chapter 6: Market Breakdown by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
  • Asia-Pacific
    • China
    • India
    • Japan
  • RoW
    • Latin America
    • Africa
    • Middle East

Chapter 7: Patent Review/ New Developments

  • Patents, by Year
  • Patents, by Type
  • Patents, by Company
  • Patents, by Country
  • Patents, by Assignee
  • New Developments
    • Prevention and Treatment of Chronic Kidney Disease
    • Use of Dynamin Ring Stabilizers
    • Compositions for the Treatment of Kidney Disease
    • Methods and Compositions in AKI
    • Treatment of CKD and Other Renal Dysfunction: GDF15 Modulator
    • Methods for Diagnosing and Assessing Kidney Disease
    • Treatment and Prevention of Chronic Kidney Disease
    • Pharmaceutical Composition for Treating Chronic Kidney Disease
    • Detection of Chronic Kidney Disease and Disease Progression
    • Methods and Composition for Diagnosis and Prognosis of Renal Injury and Renal Failure
    • Treatment for Chronic Kidney Disease
    • PromarkerD-A Predictive and Diagnostic Test for Chronic Kidney Disease

Chapter 8: Competitive Landscape

  • Overview
    • Pharmaceutical Manufacturers
    • Dialysis Equipment and Accessories Manufacturers
    • Market Share Analysis for Dialysis
    • Recent Industry Developments
  • Key Mergers and Acquisitions

Chapter 9: Company Profiles

  • ABBOTT LABORATORIES
  • ABBVIE BIOTHERAPEUTICS CORP.
  • ACCELERON PHARMA, INC.
  • ACON LABORATORIES, INC.
  • AKEBIA THERAPEUTICS, INC.
  • AM-PHARMA
  • AMAG PHARMACEUTICALS
  • AMERICAN REGENT, INC.
  • AMERICAN RENAL ASSOCIATES
  • AMGEN
  • ARDELYX
  • ARKRAY, INC.
  • ASAHI KASEI KURARAY MEDICAL CO.
  • ASTELLAS PHARMA U.S., INC.
  • ASTRAZENECA PLC
  • AURINIA PHARMACEUTICALS, INC.
  • ASTUTE MEDICAL, INC.
  • AVEO PHARMACEUTICALS, INC.
  • AWAK TECHNOLOGIES, INC.
  • B. BRAUN MEDICAL, INC.
  • BARD ACCESS SYSTEMS, INC.
  • BAXTER INTERNATIONAL, INC.
  • BAYER HEALTHCARE PHARMACEUTICALS LLC
  • BIOCAD
  • BOEHRINGER INGELHEIM
  • BRISTOL-MYERS SQUIBB
  • CANTEL MEDICAL
  • CENTERS FOR DIALYSIS CARE
  • CHEMOCENTRYX, INC.
  • CHONG KUN DANG PHARMACEUTICAL CORP.
  • CONCERT PHARMACEUTICALS, INC.
  • DAVITA, INC.
  • DIALYSIS CLINIC, INC. (DCI)
  • DIAMEDICA THERAPEUTICS, INC.
  • DIVERSIFIED SPECIALTY INSTITUTES (DSI)
  • ELI LILLY AND CO.
  • EISAI, INC.
  • FIBROGEN, INC.
  • FRESENIUS MEDICAL CARE (FMC)
  • GENENTECH, INC.
  • GLAXOSMITHKLINE
  • HOSPIRA, INC.
  • INCYTE CORP.
  • JANSSEN PHARMACEUTICALS, INC.
  • KERYX BIOPHARMACEUTICALS
  • KIDNEY CENTER, INC.
  • KRINGLE PHARMA, INC.
  • LIBERTY DIALYSIS
  • MEDCOMP
  • MEDGENICS, INC.
  • MEDICINES CO.
  • MERCK & CO.
  • MYLAN, INC.
  • NAVILYST MEDICAL
  • NEPHROGENEX, INC.
  • NIPRO CORP.
  • NORTHWEST KIDNEY CENTERS
  • NOVARTIS PHARMACEUTICALS
  • NOVO NORDISK A/S
  • NOXXON PHARMA A/G
  • NXSTAGE MEDICAL, INC.
  • OUTSET MEDICAL, INC.
  • PFIZER PHARMACEUTICAL
  • PROMETHEUS LABORATORIES, INC.
  • RENAL RESEARCH INSTITUTE (RRI) LLC
  • QUANTA FLUID SOLUTION LTD.
  • SANOFI-AVENTIS
  • SATELLITE HEALTHCARE/WELLBOUND CONCERT
  • SHIRE PHARMACEUTICALS GROUP
  • THRASOS INNOVATION
  • TRICIDA, INC.
  • U.S. RENAL CARE INC. (USRC)
  • VASCULAR ACCESS CENTERS
  • VASCULAR PHARMACEUTICALS, INC.
  • VIFOR PHARMA LTD.
Back to Top